CRANAD-29 is a promising fluorescence imaging probe for selectively monitoring brown adipose tissue mass and activation, as well as the browning of white adipose tissue in preclinical models.
Authors
No takes yet. Share an insight, caveat, or question.
Preclinical BAT imaging with curcumin analogues remains exploratory; leaves open selective probe optimization before human metabolic monitoring.
Zhang et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: